4.6 Article

Prophylactic efficacy of ketamine, but not the low-trapping NMDA receptor antagonist AZD6765, against stress-induced maladaptive behavior and 4E-BP1-related synaptic protein synthesis impairment

Related references

Note: Only part of the references are listed.
Article Neurosciences

The Resilient Phenotype Induced by Prophylactic Ketamine Exposure During Adolescence Is Mediated by the Ventral Tegmental Area-Nucleus Accumbens Pathway

Eric M. Parise et al.

Summary: The study demonstrates that KET exposure during adolescence induces a proresilient phenotype, primarily driven by Akt signaling activity within the VTA and NAc, and is dependent on VTA-NAc pathway activity.

BIOLOGICAL PSYCHIATRY (2021)

Article Neurosciences

Stress Resilience is Associated with Hippocampal Synaptoprotection in the Female Rat Learned Helplessness Paradigm

Orsolya Huzian et al.

Summary: The study found that promoting stress resilience can prevent helpless behavior in rats in the learned helplessness paradigm, while preserving spine synapses in the hippocampus. For the treatment of depression, hippocampal synaptoprotection may be as important as synaptic generation.

NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

A single administration of ascorbic acid rapidly reverses depressive-like behavior and hippocampal synaptic dysfunction induced by corticosterone in mice

Daiane B. Fraga et al.

Summary: Both ascorbic acid and ketamine can rapidly alleviate CORT-induced depressive-like behaviors and improve hippocampal synaptic markers.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

Article Neurosciences

Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway

Anderson Camargo et al.

Summary: Low doses of ketamine and/or guanosine have been shown to reverse corticosterone-induced anxiety-like behavior, but were not effective in counteracting disturbances in the hippocampal NLRP3 pathway.

PSYCHOPHARMACOLOGY (2021)

Article Behavioral Sciences

Prophylactic (R,S)-ketamine selectively protects against inflammatory stressors

Alessia Mastrodonato et al.

BEHAVIOURAL BRAIN RESEARCH (2020)

Article Clinical Neurology

Ascorbic acid presents rapid behavioral and hippocampal synaptic plasticity effects

Daiane B. Fraga et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)

Article Biochemistry & Molecular Biology

mTORC1-dependent signaling pathway underlies the rapid effect of creatine and ketamine in the novelty-suppressed feeding test

Francis L. Pazini et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2020)

Article Behavioral Sciences

The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765

Vivian B. Neis et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)

Article Endocrinology & Metabolism

Gallic acid activates hippocampal BDNF-Akt-mTOR signaling in chronic mild stress

Ji-Xiao Zhu et al.

METABOLIC BRAIN DISEASE (2019)

Article Psychiatry

Anxiolytic effects of ascorbic acid and ketamine in mice

Daiane B. Fraga et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2018)

Article Biochemistry & Molecular Biology

Cellular and molecular basis for stress-induced depression

J-S Seo et al.

MOLECULAR PSYCHIATRY (2017)

Article Neurosciences

Prophylactic Ketamine Attenuates Learned Fear

Josephine C. McGowan et al.

NEUROPSYCHOPHARMACOLOGY (2017)

Review Behavioral Sciences

Stress and psychiatric disorders: from categorical to dimensional approaches

Francesco Vailati Riboni et al.

CURRENT OPINION IN BEHAVIORAL SCIENCES (2017)

Review Neurosciences

Neurobiology of rodent self-grooming and its value for translational neuroscience

Allan V. Kalueff et al.

NATURE REVIEWS NEUROSCIENCE (2016)

Review Chemistry, Multidisciplinary

Ketamine use in current clinical practice

Mei Gao et al.

ACTA PHARMACOLOGICA SINICA (2016)

Article Neurosciences

Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior

Rebecca A. Brachman et al.

BIOLOGICAL PSYCHIATRY (2016)

Review Psychology, Clinical

KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS

Chadi G. Abdallah et al.

DEPRESSION AND ANXIETY (2016)

Article Behavioral Sciences

Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice

Priscila B. Rosa et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)

Review Clinical Neurology

The hippocampal-prefrontal pathway: The weak link in psychiatric disorders?

Bill P. Godsil et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)

Review Neurosciences

Signaling pathways underlying the rapid antidepressant actions of ketamine

Ronald S. Duman et al.

NEUROPHARMACOLOGY (2012)

Article Biochemistry & Molecular Biology

mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action

Ghada A. Soliman et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Review Neurosciences

Stress signalling pathways that impair prefrontal cortex structure and function

Amy F. T. Arnsten

NATURE REVIEWS NEUROSCIENCE (2009)

Article Biochemical Research Methods

Analyzing grooming microstructure in neurobehavioral experiments

Allan V. Kalueff et al.

NATURE PROTOCOLS (2007)

Article Psychiatry

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Carlos A. Zarate et al.

ARCHIVES OF GENERAL PSYCHIATRY (2006)

Review Neurosciences

Stress and the brain:: From adaptation to disease

ER de Kloet et al.

NATURE REVIEWS NEUROSCIENCE (2005)

Article Pharmacology & Pharmacy

Mouse grooming microstructure is a reliable anxiety marker bidirectionally sensitive to GABAergic drugs

AV Kalueff et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2005)

Article Neurosciences

Antidepressant effects of ketamine in depressed patients

RM Berman et al.

BIOLOGICAL PSYCHIATRY (2000)